MURUGAPPAN M et al. 2025. ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT. Asian Journal of Pharmaceutical and Clinical Research. 18, 4 (Apr. 2025), 44–51. DOI:https://doi.org/10.22159/ajpcr.2025v18i4.54004.